share_log

新興市場銘柄ダイジェスト:ELTA-Pは大幅に反発、ジャパニアスが年初来安値

Emerging Market Stock Digest: ELTA-P rebounds drastically, Japanias is low year-to-date

Fisco Japan ·  Apr 9 15:03

<6579> Logley 546 +8

Continued significant growth. It has been announced that the service “Buzz Lista,” which supports performance-guaranteed influencer marketing, has been officially released. A total solution for influencer policies that provides one-stop support from casting to video production, and subsequent advertisement distribution and results analysis. The biggest characteristic is that the “number of views” is guaranteed (minimum guarantee) according to the budget, and for example, if the budget is 500,000 yen, 500,000 views are guaranteed at least.

<9558> Japanias 2630 -500

Year-to-date low. Operating profit for the first quarter (23/12/24 to 2/24) of the fiscal year ending 2014/11 was announced to be 147 million yen, down 25.5% from the same period last year. IT-related market conditions became a tailwind, and sales remained steady at 2,665 billion yen, up 16.5% due to an increase in orders for high-unit price projects, but since active investments were made by hiring engineers, SG&A expenses increased, and profit declined. The full-year operating profit forecast remained unchanged at 1,020 billion yen, up 22.0% from the previous fiscal year.

<168A> Damaged Art 1809 +56

High temporary stop. It was newly listed the day before and the first price was set at 2000 yen, which is higher than the public price (1600 yen), but at the closing price, the level was devalued to 1753 yen, and today buyers are gathering due to a sense of affordability. We are involved in the planning and sale of large-scale sales promotion products through EC sites for BtoB, and the operating profit forecast for the fiscal year ending 25/1 is 244 million yen, up 26.7% from the previous fiscal year. In addition to the recent level of attention as an initial public offering (IPO) stock, strong earnings forecasts also seem to induce investors' sense of security in buying.

<5892> yutori 1970 -54

Significant backlash. The Tokyo Stock Exchange has lifted regulatory measures relating to margin trading since the 9th, and purchases are underway due to expectations for revitalizing trading. Until the day before, the Tokyo Stock Exchange had implemented regulatory measures to set the contract deposit rate of 50% or more (of which 20% or more in cash) relating to new sales and purchases. Nippon Stock Exchange has also lifted additional security deposit collection measures by brand for loan transactions. Yutori stocks had plummeted by 14% or more the day before, and there seems to be a rush of buying.

<2158> FRONTEO 655 +14

Significant rebound for the first time in 3 days. It has been announced that the “Novel Targets Library,” which introduces target genes with high novelty and potential, has been established. As part of introducing our own technology, we are utilizing a new analysis method to visualize target genes with high potential for drug discovery using the AI “KIBIT” developed in-house. As the first step, a novel target gene for “hypertension” was disclosed. It is said that diseases are being added sequentially in the future.

<4598> DELTA-P 847 +39

Significant backlash. It has been announced that the U.S. Food and Drug Administration (FDA) has authorized the implementation of a clinical phase 1/2 trial of the developed product “DFP-10917” and VTX combination therapy targeting acute myeloid leukemia (AML) patients with a history of venetoclax (VTX) treatment (1 time). The purpose is to determine the possibility that AML can surpass standard therapy (combination therapy with azacitidine and VTX). DFP-10917 is an intravenous infusion indicated for AML (refractory/recurrent).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment